iShares 10 20 Year Treasury Bond ETF vs UnitedHealth Group Inc — how do they compare? iShares 10 20 Year Treasury Bond ETF trades at $96.05, while UnitedHealth Group Inc trades at $394.14 (market cap $359.79B). The key difference: UnitedHealth Group Inc pays a 2.32% dividend while iShares 10 20 Year Treasury Bond ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| TLH | UNH | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $105.36 | $436.35 |
52-Week Low | $96.08 | $259.02 |
Market Cap | — | $359.79B |
Enterprise Value | — | $401.65B |
Dividend Yield | — | 2.32% |
Signals from Pluang's Aura AI — not financial advice
TLH trades at $96.52, down 0.09% on the day, with a bearish technical signal from moving averages but a neutral reading from oscillators. Recent corporate actions include dividend payments scheduled for 2026. Key support and resistance levels are tightly clustered around $96-$97. Financial ratios such as P/E, P/S, and ROE are not provided in the current data snapshot.
The outlook for TLH is clouded by the lack of recent fundamental data, making valuation difficult. Investment opportunity hinges on future earnings clarity and dividend sustainability. Risks include market volatility, macroeconomic pressures from rising bond yields and oil prices, and potential impacts from geopolitical tensions on broader equity sentiment.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Trailing returns across standard periods
Latest headlines on both assets
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →